Outsourcing

Jul 11, 2017
By BioPharm International Editors
GE Healthcare’s Dharmacon business and CordenPharma contract manufacturing enter a strategic collaboration to accelerate the oligonucleotide development process.
Jul 06, 2017
By BioPharm International Editors
A $5.5 billion acquisition brings Capsugel’s oral dosage delivery capabilities to Lonza’s portfolio.
Jul 05, 2017
By BioPharm International Editors
Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.
Jul 05, 2017
By BioPharm International Editors
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
Jun 01, 2017
BioPharm International
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
May 15, 2017
BioPharm International
This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.
May 15, 2017
BioPharm International
FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
May 15, 2017
BioPharm International
Effective communication between contract manufacturing organizations and pharmaceutical company clients relies on well-defined master service and quality agreements.
May 15, 2017
BioPharm International
The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
May 15, 2017
BioPharm International
Contract manufacturers prepare for anticipated biosimilars manufacturing demands through expansion and acquisition.
native1_300x100
lorem ipsum